MediPal Holdings Company Description
Medipal Holdings Corporation engages in the prescription pharmaceutical wholesale business in Japan.
It procures healthcare products related to diagnostics, testing, treatment, and administration comprising medical equipment and medical materials, and clinical diagnostic reagents for use from the pre-symptomatic stage; handles PMS services on contract for manufacturers; and invests in orphan drugs and other products.
The company is also involved in the wholesale of cosmetics, daily necessities, and OTC pharmaceuticals; and animal health products for companion animals; and food processing raw materials for agriculture, fisheries, and livestock.
In addition, it engages in the contract-based epidemiological studies, clinical studies, etc.; creation of a computerized medical supply database and master product databases for medical facilities; life and non-life insurance agency business; cleaning management; management and operation of distribution centers; commissioned delivery and worker dispatch business; planning, management, administration, and product and service development for the class A health dispensing pharmacies service brand; and distributes specialty pharmaceuticals.
Further, the company is involved in contract logistics services; information provision services; health insurance claims review, medical coding dispatch, outsourcing and remote education; and creation of a medical supply database and master product databases for medical facilities.
It serves hospitals, clinics, dispensing pharmacies, drugstores, home centers, convenience stores, supermarkets, discount stores, animal hospitals, livestock and fish producers, and processed food manufacturers.
The company was formerly known as Mediceo Paltac Holdings Co., Ltd. and changed its name to Medipal Holdings Corporation in October 2009.
Medipal Holdings Corporation was founded in 1898 and is headquartered in Tokyo, Japan.
Country | Japan |
Founded | 1898 |
Industry | Medical Distribution |
Sector | Healthcare |
Employees | 13,061 |
CEO | Shuichi Watanabe |
Contact Details
Address: 3-1-1 Kyobashi Tokyo, 104-8461 Japan | |
Phone | 81 3 3517 5800 |
Website | medipal.co.jp |
Stock Details
Ticker Symbol | MEPDF |
Exchange | OTCMKTS |
Stock Type | Common Stock |
Fiscal Year | April - March |
Reporting Currency | JPY |
ISIN Number | JP3268950007 |
SIC Code | 5122 |
Key Executives
Name | Position |
---|---|
Shuichi Watanabe | Chief Compliance Officer, Chief Executive Officer, President and Representative Director |
Yuji Sakon | MD, GM of Administration Division and Director |
Toshihide Yoda | Senior MD of Investor Relations, GM of Business Development Department and Director |
Yasuhiro Choufuku | Executive Vice President and Representative Director |
Shinjiro Watanabe | GM of Information Systems Management Division and Director |
Imagawa Kuniaki | Deputy Head of Pharmaceutical Business and Director |